These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 25072260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial-Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α.
    Qian J, Shen S, Chen W, Chen N.
    Biomed Res Int; 2018; 2018():4174232. PubMed ID: 29568752
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
    Alshaker H, Wang Q, Kawano Y, Arafat T, Böhler T, Winkler M, Cooper C, Pchejetski D.
    Oncotarget; 2016 Dec 06; 7(49):80943-80956. PubMed ID: 27821815
    [Abstract] [Full Text] [Related]

  • 5. Isoflurane preconditioning increases survival of rat skin random-pattern flaps by induction of HIF-1α expression.
    Sun Y, Li QF, Zhang Y, Hu R, Jiang H.
    Cell Physiol Biochem; 2013 Dec 06; 31(4-5):579-91. PubMed ID: 23635649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of hypoxia-inducible factor-1α and -2α in androgen insensitive prostate cancer cells.
    Jeong CW, Yoon CY, Jeong SJ, Hong SK, Byun SS, Kwak C, Lee SE.
    Urol Oncol; 2013 Nov 06; 31(8):1448-56. PubMed ID: 22537539
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
    Mirzoeva S, Kim ND, Chiu K, Franzen CA, Bergan RC, Pelling JC.
    Mol Carcinog; 2008 Sep 06; 47(9):686-700. PubMed ID: 18240292
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer.
    Yang N, Liang Y, Yang P, Ji F.
    Oncol Rep; 2017 May 06; 37(5):2611-2619. PubMed ID: 28426124
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor.
    Chen X, Wu Q, You L, Chen S, Zhu M, Miao C.
    Eur J Pharmacol; 2017 Jan 15; 795():150-159. PubMed ID: 27986626
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.
    Park JJ, Jin YB, Lee YJ, Lee JS, Lee YS, Ko YG, Lee M.
    BMC Cancer; 2012 Mar 06; 12():81. PubMed ID: 22390300
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells.
    Befani CD, Vlachostergios PJ, Hatzidaki E, Patrikidou A, Bonanou S, Simos G, Papandreou CN, Liakos P.
    J Mol Med (Berl); 2012 Jan 06; 90(1):45-54. PubMed ID: 21909688
    [Abstract] [Full Text] [Related]

  • 20. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y, Zhao X, Tang H, Zhong Z, Zhang L, Xu R, Li S, Wang Y.
    Urol Int; 2012 Jan 06; 88(1):95-101. PubMed ID: 22041818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.